Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
B
064550
vs
K
KOSPI 200
Over the past 12 months, BioneerCorp has underperformed KOSPI 200, delivering a return of -34% compared to KOSPI 200's +116% growth.
Stocks Performance
064550 vs KOSPI 200
Performance Gap
064550 vs KOSPI 200
Performance By Year
064550 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
BioneerCorp
Glance View
BioneerCorp is a South Korean life-science company that develops tools and reagents used in molecular biology and genetic testing. Its products include DNA and RNA extraction kits, PCR and sequencing-related reagents, and laboratory instruments that help researchers and clinical labs prepare and analyze biological samples. In simple terms, it sells the equipment and consumables that make genetic analysis possible. Its main customers are research institutes, hospitals, diagnostic labs, universities, and biotech or pharmaceutical companies. Bioneer makes money by selling instruments upfront and then earning repeat revenue from the kits, chemicals, and other consumables those instruments need. That mix matters because the installed customer base can keep buying supplies over time, not just once. What makes Bioneer different is its role as a specialized supplier in the genetics workflow rather than a drug developer or a broad medical device company. It sits upstream in the testing chain, helping customers extract, prepare, and amplify DNA and RNA before those samples are analyzed. That makes the business closely tied to the growth of research and molecular diagnostics, with revenue coming from both hardware and recurring laboratory products.